Medicare CHOICE Act of 2018

Summary

Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018 This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

6 official files

• Reported in House (text)

  Reported in House · EN · 12 June 2018

  ViewDownloadOpen at official source

• Reported in House (PDF)

  Reported in House · EN · 12 June 2018

  ViewDownloadOpen at official source

• Reported to House without amendment, Part I

  summary · EN · 12 June 2018

  Open at official source

• Introduced in House (text)

  Introduced in House · EN · 7 May 2018

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 7 May 2018

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 7 May 2018

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.